Eric C. Huang, MD, PhD Associate Professor Director, Cytopathology Service & HPV Molecular Diagnostic Laboratories Program Director, Cytopathology Fellowship Department of Laboratory Medicine & Pathology University of Washington Objectives: - Describe the cervical cancer screening guidelines.
- Apply the latest ASCCP risk-based management guidelines for cervical abnormalities.
- Understand the pearls and pitfalls of primary HPV screening.
Speaker disclosures: Dr. Eric C. Huang has NOT had any financial relationships with any ineligible entities within the past 24 months. Why Attend? A standard approach to managing patients with abnormal cervical cytology and cervical cancer precursors was initially developed by ASCCP in 2001 and updated in 2006 and 2012. Since then, our understanding of cervical disease has advanced and screening has changed. Clinicians would benefit from guidance on how to incorporate the newly developed risk-based management guidelines into their routine practice. Attendees will learn the risk estimates based on patient characteristics and current and prior test results. In addition, current screening strategy has shifted to primary HPV as the preferred method. The impact and pitfalls of primary HPV screening will be presented. After this session, the attendees will understand the current screening and management guidelines in cervical cancer screening. Meeting ID: 983 8715 9855 Passcode: PATHGR You must sign-in on the following form to receive CME credit. Sign-in online: https://forms.gle/W2oE8d3MYbnyTDe58
Planning Committee Disclosure: The following members have not had any financial relationships with any ineligible entities in the past 24 months: Drs. Rebecca Alvarez, Eleanor Chen, Austin Green, Jose Mantilla, Isaac Miller, Elizabeth Parker, Maria Tretiakova, and Larry True. The following members disclose financial relations with ineligible entities within the past 24 months: Dr Shreeram Akilesh GoldfinchBio, Inc. (sponsored research) and NanoString, Inc. (sponsored travel); and Dr. Haodong Xu PathomIQ (consultant). All relevant financial relationships listed have been mitigated.
Grant Acknowledgment: None
CME Accreditation statement: The University of Washington School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The University of Washington School of Medicine designates this live activity for a maximum of 10.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. (Each session is 1.0 credit) |